Avadel Pharmaceuticals PLC REST-ON Phase 3 Trial Data Call Transcript
Greetings, and welcome to the Avadel Pharmaceuticals data call and webcast. (Operator Instructions) As a reminder, this conference is being recorded. It's now my pleasure to introduce your host, Tom McHugh, Chief Financial Officer. Please go ahead, sir.
Good morning, and thank you for joining us on our conference call. On the call with me today are Greg Divis, Chief Executive Officer; and Dr. Jordan Dubow, Chief Medical Officer of Avadel. This morning, we should have released with top line data results from the Phase III REST-ON study. The release can be accessed on our website, www.avadel.com.
As a reminder, before we begin, the following presentation includes several matters that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |